Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Porta Sophia is a Madison, Wisconsin-based nonprofit organization focused on psychedelics and the intellectual property landscape surrounding psychedelic therapies. Rather than developing drugs, it curates a searchable library of scientific, historical, cultural, archival, and other prior art related to psychedelic compounds and uses that database to support patent review, patentability assessments, freedom-to-operate analysis, and third-party patent interventions. The organization works to prevent overly broad or invalid psychedelic patents while supporting defensible, novel patents and broader access to psychedelic therapies. Its users include innovators, patent practitioners, investors, the public, and patent examiners. Porta Sophia has also been recognized by the USPTO as an official prior art resource for this niche.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Porta Sophia.